The results indicate that both compounds prominently regulate cancer-associated pathways, including neuroactive ligand–receptor interaction, MAPK signaling, and PI3K-Akt signaling (Figure S1), suggesting their potential as bioactive components targeting oncogenic signaling. The gene discussed is AKT1; the disease is cancer.